James Woodruff Lillie, Chief Scientific Officer at MapLight Therapeutics, Inc. (MPLT), sold 22,082 shares at $12.54 ($277K) on 2026-08-03, disclosed to the SEC on 2026-08-04.
Scheduled sale ($277k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MPLT | SELL | 2026-05-06 | $1.5M | — | Filing → |
| MPLT | SELL | 2026-04-17 | $123K | — | Filing → |